Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010-2011
- PMID: 23084847
- DOI: 10.1016/j.vaccine.2012.10.024
Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010-2011
Abstract
Background: Influenza epidemics are accompanied by a considerable increase in hospitalization due to acute lower respiratory infection and exacerbation of underlying medical conditions. We estimated the effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and new onset or acute exacerbation of chronic cardiopulmonary disease.
Method: During the peak influenza period in 2010-2011, we performed a multicenter, case-control, retrospective cohort study of patients who were hospitalized due to newly developed pneumonia, bronchitis, and bronchiolitis, or new onset or acute exacerbation of asthma, COPD, ischemic heart disease, and CHF. Controls were selected from outpatients who visited study hospitals but who were not hospitalized during the same study period. Controls were matched 1:1 to cases based on age, gender, and date of hospital visit. Univariate and multivariate logistic regression analyses were used to determine the effectiveness of the influenza vaccine at decreasing hospitalization.
Results: Between December 2010 and February 2011, 556 hospitalized subjects were identified. Age, gender, and body mass index (BMI) were similar between case and control groups. The influenza vaccination rate of the hospitalized and non-hospitalized patients was 42.4% and 52.2%, respectively (p<0.001). The overall vaccine effectiveness for preventing hospitalization was 32.5% (odds ratio 0.675, 95% confidence interval [CI] 0.486-0.937; p=0.019). Multivariate logistic analysis showed that influenza vaccination significantly reduced the risk of hospitalization, especially due to new onset or acute exacerbation of ischemic heart disease and CHF in patients aged 65 years and older (OR 0.274, 95% CI 0.114-0.658, p=0.004). The estimated vaccine effectiveness in these patients was 72.6%.
Conclusion: Influenza vaccination reduced the rate of hospitalization among patients with underlying chronic heart disease, particularly those patients 65 years old and greater.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012.Hum Vaccin Immunother. 2014;10(2):423-7. doi: 10.4161/hv.26858. Epub 2013 Oct 25. Hum Vaccin Immunother. 2014. PMID: 24161939 Free PMC article.
-
Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.Vaccine. 2012 Aug 17;30(38):5644-50. doi: 10.1016/j.vaccine.2012.06.090. Epub 2012 Jul 10. Vaccine. 2012. PMID: 22796136
-
Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.Clin Infect Dis. 2013 Jul;57(2):167-75. doi: 10.1093/cid/cit194. Epub 2013 Mar 26. Clin Infect Dis. 2013. PMID: 23532475
-
Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.Ther Adv Respir Dis. 2016 Aug;10(4):349-67. doi: 10.1177/1753465816646050. Epub 2016 May 18. Ther Adv Respir Dis. 2016. PMID: 27193567 Free PMC article. Review.
-
[Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].Nihon Rinsho. 2016 May;74(5):839-42. Nihon Rinsho. 2016. PMID: 27254956 Review. Japanese.
Cited by
-
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults.Infect Chemother. 2013 Jun;45(2):159-74. doi: 10.3947/ic.2013.45.2.159. Epub 2013 Jun 26. Infect Chemother. 2013. PMID: 24265964 Free PMC article. Review.
-
Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.PLoS One. 2018 Dec 6;13(12):e0207918. doi: 10.1371/journal.pone.0207918. eCollection 2018. PLoS One. 2018. PMID: 30521553 Free PMC article.
-
Association between Psychological Flexibility and Health Beliefs in the Uptake of Influenza Vaccination among People with Chronic Respiratory Diseases in Hong Kong.Int J Environ Res Public Health. 2016 Jan 23;13(2):155. doi: 10.3390/ijerph13020155. Int J Environ Res Public Health. 2016. PMID: 26805870 Free PMC article.
-
Antiviral potentials of garlic (Allium sativum) in poultry production: A mini review.Vet Med Sci. 2023 Nov;9(6):2711-2718. doi: 10.1002/vms3.1247. Epub 2023 Aug 30. Vet Med Sci. 2023. PMID: 37647249 Free PMC article. Review.
-
Perception and Attitudes of Korean Obstetricians about Maternal Influenza Vaccination.J Korean Med Sci. 2016 Jul;31(7):1063-8. doi: 10.3346/jkms.2016.31.7.1063. Epub 2016 May 16. J Korean Med Sci. 2016. PMID: 27366003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical